CLINICAL_TRIALS ClinicalTrials.gov record update

Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06706921
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:05.556004+00:00
Published At: 2024-11-27T00:00:00+00:00
Record Updated At: 2024-11-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Prostatic Neoplasms", "Prostatic Neoplasms, Castration-Resistant", "Metastatic Prostate Cancer", "Male Urogenital Diseases", "Prostatic Diseases", "Urogenital Diseases, Male", "Genital Diseases, Male", "Neoplasms", "Neoplasms by Site", "Urogenital Neoplasms", "Genital Neoplasms, Male"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-11-27"
protocolSection.identificationModule.nctId: "NCT06706921"
protocolSection.identificationModule.officialTitle: "Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.